Publication Name	World Journal of Diabetes
Manuscript ID	7191
Country	Australia

Received	2013-11-08 19:48
Peer-Review Started	2013-11-09 20:44
To Make the First Decision	2014-02-13 16:29
Return for Revision	2014-02-20 09:08
Revised	2014-02-28 14:03
Second Decision	2014-03-18 14:58
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-18 15:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-04-11 09:53
Publish the Manuscript Online	2014-04-18 11:34

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Review
Article Title	Origin and therapy for hypertriglyceridaemia in type 2 diabetes
Manuscript Source	Invited Manuscript
All Author List	Jing Pang, Dick C Chan and Gerald F Watts
Funding Agency and Grant Number
Corresponding Author	Gerald F Watts, DSc, MD, PhD, FRACP, FRCP, School of Medicine and Pharmacology, University of Western Australia, GPO Box X2213, Perth, WA 6847, Australia. gerald.watts@uwa.edu.au
Key Words	Diabetes; Triglyceride; Therapy
Core Tip	Diabetic dyslipidemia relates collectively to hyperglycaemia, insulin resistance, hyperinsulinaemia, abdominal visceral adipose disposition, increased liver fat content, and dysregulated fatty acid metabolism. Insulin resistance in diabetes induces hypertriglyceridaemia by increasing the enterocytic production of chylomicrons and an impaired clearance capacity is also involved. Usual care for diabetic dyslipidemia is statin treatment, but a significant proportion of patients have residual dyslipidemia, related to hypertriglyceridaemia and atherogenic dyslipidemia. Current evidence supports the use of fenofibrate in type 2 diabetics with high triglyceride levels.
Publish Date	2014-04-18 11:34
Citation	Pang J, Chan DC, Watts GF. Origin and therapy for hypertriglyceridaemia in type 2 diabetes. World J Diabetes 2014; 5(2): 165-175
URL	http://www.wjgnet.com/1948-9358/full/v5/i2/165.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i2.165

Full Article (PDF)	WJD-5-165.pdf
Full Article (Word)	WJD-5-165.doc
Manuscript File	7191-Review.docx
Answering Reviewers	7191-Answering reviewers.pdf
Copyright License Agreement	7191-Copyright assignment.pdf
Peer-review Report	7191-Peer reviewer(s).pdf
Scientific Editor Work List	7191-Scientific editor work list.doc